Regional citrate anticoagulation vs systemic heparin anticoagulation for double-filtration plasmapheresis.

Swee Ping Teh Quan Yao HoYi Shern Terence KeeSobhana ThangarajuRu Yu TanSu Hooi TeoHan Khim TanChieh Suai TanHui Lin Lina ChoongLi Choo NgMaslinna Abdul RahmanAmy Ee Lin LimManish Kaushik

Published in: Journal of clinical apheresis (2022)

Amongst kidney transplant patients who receive DFPP therapy, RCA-DFPP may be comparable to Hep-DFPP for the maintenance of circuit patency. Functioning vascular access is vital in avoiding premature clotting of the circuit. Close monitoring of electrolyte imbalances and coagulopathy related to DFPP is recommended.

Keyphrases

venous thromboembolism
atrial fibrillation
ionic liquid
growth factor
stem cells
drug induced
ion batteries
bone marrow
replacement therapy